Delta Capital Management LLC Amgen Inc Transaction History

Delta Capital Management LLC

$265 Million
Q3 2024

A detailed history of Delta Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Delta Capital Management LLC holds 9,065 shares of AMGN stock, worth $2.67 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

9,065

Previous 9,065 -0.0%

Holding current value

$2.67 Million

Previous $2.83 Million 3.11%

% of portfolio

1.1%

Previous 1.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 0.11%	9,065 $2.61 Million
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $52,476 - $65,150	-240 Reduced 2.58%	9,075 $2.44 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $6,428 - $7,601	-30 Reduced 0.32%	9,315 $2.07 Million
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $9,031 - $11,008	-40 Reduced 0.43%	9,345 $2.26 Million
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $3,435 - $4,365	15 Added 0.16%	9,385 $2.47 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $4,614 - $5,134	20 Added 0.21%	9,370 $2.28 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $248,871 - $275,316	-1,135 Reduced 10.82%	9,350 $2.26 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $2,983 - $3,414	15 Added 0.14%	10,485 $2.36 Million
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 0.19%	10,470 $2.23 Million
Q2 2021 Jul 23, 2021	SELL	$233.58 - $259.14 $7,007 - $7,774	-30 Reduced 0.29%	10,490 $2.56 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $28,848 - $33,618	130 Added 1.25%	10,520 $2.62 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $41,063 - $45,666	-175 Reduced 1.66%	10,390 $2.64 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $466,831 - $572,866	-2,360 Reduced 18.26%	10,565 $2.49 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $18,224 - $24,170	-100 Reduced 0.77%	12,925 $2.62 Million
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $179,333 - $214,878	-1,030 Reduced 7.33%	13,025 $2.52 Million
Q2 2019 Jul 22, 2019	SELL	$166.7 - $195.41 $26,672 - $31,265	-160 Reduced 1.13%	14,055 $2.59 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $10,852 - $12,232	-60 Reduced 0.42%	14,215 $2.7 Million
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $12,488 - $14,577	-70 Reduced 0.49%	14,275 $2.78 Million
Q3 2018 Oct 10, 2018	BUY	$185.29 - $208.89 $41,690 - $47,000	225 Added 1.59%	14,345 $2.97 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $13,284 - $14,920	-80 Reduced 0.56%	14,120 $2.61 Million
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $32,191 - $37,620	-190 Reduced 1.32%	14,200 $2.42 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $31,226 - $34,889	-185 Reduced 1.27%	14,390 $2.5 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $2.44 Million - $2.78 Million	14,575	14,575 $2.72 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Capital Management LLC with notifications on news.

Account

Delta Capital Management LLC Amgen Inc Transaction History